# Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Study · id `cardio:ct-nct01953874` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01953874](<https://clinicaltrials.gov/study/NCT01953874>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01953874

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 126 participants.

## Technical summary

Registry record NCT01953874. Randomized; no masking; primary purpose supportive care. Start 2013-12 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2018-02-28.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 126 participants (enrolled count; ClinicalTrials.gov record NCT01953874, source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)
- Start date: 2013-12 (registry gives no type) (ClinicalTrials.gov record NCT01953874, source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01953874, source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01953874, source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)
- Results first posted: 2018-02-28 (ClinicalTrials.gov record NCT01953874, source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)
- Countries: United States; Germany (ClinicalTrials.gov record NCT01953874, source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01953874-2018-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cardiovascular Improvements With MV ASV Therapy in Heart Failure
- Acronym: CAT-HF
- Condition: Acute Decompensated Heart Failure
- Condition: Sleep Disordered Breathing
- Intervention (Device): MV ASV
- Intervention (Drug): Optimized Medical Treatment
- Lead sponsor: ResMed
- Lead sponsor class: INDUSTRY
- Collaborator: ResMed Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: ResMed (`cardio:org-resmed`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial (`cardio:pubmed-28335841`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea (`cardio:pubmed-30059750`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4502d0361a6006976085f01fdd0b184919fe9a1efb060c9bc993c30db9e2844e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
